InflammaDry

Numbers transform dry eye treatment for symptomatic, asymptomatic patientsAdding objective point-of-care dry eye diagnostics to your practice has deep, measurable effects, including more accurate and consistent IOL power calculations.
Reviewing anterior segment ARVO 2017 postersSo much basic science research is presented at this meeting, and most of it will be years before it makes its way to clinical trials. Let’s concentrate on research that might be of use to us in the exam room very soon.
How tear proteomics can help optometryODs undervalue ocular point-of-care tear testing
In-office lab testing provides diagnostic informationSimilar to the benefits that the primary care and pediatrics fields have enjoyed following years of rapid strep and flu testing, the uptake of rapid, single-use, point-of-care (POC) testing in optometry helps to guide clinical management and therapeutic decisions.
Incorporating lactoferrin and immunoglobin testingWhile ophthalmic diagnostic lab tests—specifically those targeting ocular surface disorders—have been around for over 20 years, it is only within the past five years that they have begun to gain measurable use.
The utility of normal tear osmolarity results
The utility of normal tear osmolarity resultsPatient symptoms are not an effective method to diagnose dry eye, as they often overlap with other pathologies. Tear osmolarity results provide clues for alternative diagnoses.
How digital device usage is affecting youthThe time we are spending on digital devices is on the rise, and it’s unlikely to slow down any time soon. With more and more apps, games, and social media options, we have all become more dependent on smartphones, tablets, and other electronic devices.
Ocular surface disease limits surgical optionsPrepare your patient by assessing and treating the ocular surface
How to get non-symptomatic dry eye patients to comply with treatment
How to get non-symptomatic dry eye patients to comply with treatmentDr. Scott Schachter offers advice on how to better manage non-symptomatic dry eye patients and encourage them to comply with your treatment plan
Incorporating meibomian gland imagingAdding this technology can improve your diagnosis and better educate your patients